| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
ALX Oncology Holdings Inc.
13D/A
ALXO · 00166B105
|
2.2% |
5/27/2026
Event 5/27/2026
|
||||
| LSV Associates, LLC | 1.2% | |||||
| Lightstone Ventures, L.P. | 1.0% | |||||
| Lightstone Ventures (A), L.P. | 0.1% | |||||
| LSV Associates II, LLC | 1.0% | |||||
| Lightstone Ventures II, L.P. | 1.0% | |||||
| Lightstone Ventures II (A), L.P. | 0.1% | |||||
| Michael A Carusi | 2.2% | |||||
| Jean George | 2.2% | |||||
| Henry A. Plain Jr | 2.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.